$Clinical Significance of Measurable Residual Disease (MRD) in Relapsed/Refractory Multiple Myeloma (RRMM) Patients (Pts) Treated with Chimeric Antigen Receptor (CAR) T Cells and T-Cell Engagers (TCE)$

Clinical Significance of Measurable Residual Disease (MRD) in Relapsed/Refractory Multiple Myeloma (RRMM) Patients (Pts) Treated with Chimeric Antigen Receptor (CAR) T Cells and T-Cell Engagers (TCE)

Background: CAR T cells and TCE are approved for the treatment of RRMM and are being investigated in newly diagnosed pts. Because their mode of action differs with respect to other drugs used in MM, the clinical significance of conventional prognostic factors must be reanalyzed in the era of newer i...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Blood 2023-11, Vol.142 (Supplement 1), p.94-94
Hauptverfasser:	Zabaleta, Aintzane, Puig, Noemi, Cedena Romero, Maria Teresa, Perez, Jose J, Moreno, Cristina, Tamariz-Amador, Luis-Esteban, Rodriguez Otero, Paula, Gonzalez-Calle, Veronica, Lopez Corral, Lucia, Rey-Búa, Beatriz, Puertas Martínez, Borja, Miras, Fatima, Sanchez-Pina, Jose, Lopez, Nieves, Martinez-Lopez, Joaquin, Mateos, Maria Victoria, San-Miguel, Jesus, Paiva, Bruno
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!